Press Releases

Regenesis Achieves FDA Clearance for the New Reprieve by Regenesis Device

SCOTTSDALE/ August 22, 2023/ PRNewswire/ – Regenesis Biomedical, Inc., a medical devic­­e company focused on safe, non-drug, pain management, announced today commercialization of the new Reprieve by Regenesis™ device (Reprieve).  Reprieve is the only home-use shortwave diathermy device on the market and is based on Regenesis’ core pulsed electromagnetic energy platform.Read More…